| 摘要 |
<p>Drugs containing as the active ingredient substances selected from the group consisting of phenylacetic acid derivatives represented by general formula (I), their physiologically acceptable salts and hydrates, and solvates thereof. In said formula (I) R1 represents hydrogen or R5CO- (wherein R5 represents C¿1-6? alkyl or C¿6-10 aryl); R?2 and R3¿ independently represent each hydrogen or C¿1-4? alkyl; and R?4¿ represents hydrogen or C¿1-6? alkyl; and being useful in preventing and/or treating diseases caused by abnormal neovascularization such as cancer, rheumatoid arthritis, atherosclerosis, diabetic retinitis, hemangioma, psoriasis, etc.</p> |
